咳止めシロップの市場規模、シェア、成長分析：製品別、年齢層別、流通別、地域別 - 産業予測、2025年～2032年

咳止めシロップの世界市場規模は2023年に52億米ドルと評価され、予測期間（2025-2032年）のCAGRは4.0%で、2024年の54億1,000万米ドルから2032年には74億米ドルに成長する見通しです。

世界の咳止めシロップ市場は、革新的な製剤の研究開発に対する大手製薬会社の多額の投資により、有望な成長軌道に乗っています。咳に関連する問題の迅速な管理に関する消費者の意識の高まりが、市場拡大をさらに後押ししています。各社は戦略的提携、製品の上市、ターゲットを絞ったマーケティング活動を活用し、競争力を高めています。また、オンライン購入プラットフォームの利便性も市場アクセシビリティを高め、消費者が多様な製品の選択肢を容易に検討できるようにしています。地域的には、どの地域でも需要が顕著に増加しており、特にヘルスケアのインフラが整備され、可処分所得が増加している新興国では顕著です。加えて、ハーブや天然素材の代替品へのシフトが市場力学を再構築しています。規制上の課題や誤用の懸念はあるもの、市場の見通しは依然として明るいです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

咳止めシロップ市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 去痰薬
• 咳止め薬
• 抗ヒスタミン薬
• 併用薬

咳止めシロップ市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 小児
• 成人

咳止めシロップ市場規模：流通別& CAGR（2025-2032）

• 市場概要
• 小売り
• 薬局
• 病院
• その他

咳止めシロップ市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Johnson & Johnson（USA）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Sanofi S.A.（France）
• Bayer AG（Germany）
• Reckitt Benckiser Group plc（UK）
• Procter & Gamble（USA）
• Prestige Consumer Healthcare Inc.（USA）
• Church & Dwight Co., Inc.（USA）
• Dabur India Ltd.（India）
• Himalaya Wellness Company（India）
• Cipla Ltd.（India）
• Sun Pharmaceutical Industries Ltd.（India）
• Mankind Pharma Ltd.（India）
• Perrigo Company plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Mylan N.V.（USA）
• Perrigo Company plc（Ireland）
• Valeant Pharmaceuticals International, Inc.（Canada）
• Medtech Products Inc.（USA）

結論と推奨事項

Global Cough Syrup Market size was valued at USD 5.2 billion in 2023 and is poised to grow from USD 5.41 billion in 2024 to USD 7.4 billion by 2032, growing at a CAGR of 4.0% during the forecast period (2025-2032).

The Global Cough Syrup Market is on a promising growth trajectory, driven by significant investments from major pharmaceutical companies in research and development of innovative formulations. Increased consumer awareness regarding the prompt management of cough-related issues further fuels market expansion. Companies are leveraging strategic partnerships, product launches, and targeted marketing efforts to enhance their competitive positions. The convenience of online purchasing platforms also boosts market accessibility, enabling consumers to explore diverse product options easily. Geographically, all regions are experiencing notable increases in demand, especially in emerging economies with advancing healthcare infrastructure and rising disposable incomes. Additionally, the shift towards herbal and natural alternatives is reshaping market dynamics. Despite regulatory challenges and concerns over misuse, the market outlook remains positive.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cough Syrup market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cough Syrup Market Segmental Analysis

Global Cough Syrup Market is segmented by Product, Age Group, Distribution and region. Based on Product, the market is segmented into Expectorants, Cough Suppressants, Antihistamines and Combination Medication. Based on Age Group, the market is segmented into Pediatric and Adult. Based on Distribution, the market is segmented into Retail, Pharmacy, Hospital and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cough Syrup Market

A significant factor fueling the global cough syrup market is the rising incidence of respiratory disorders across the globe. The surge in respiratory ailments can be attributed to several factors, including escalating air pollution levels, fluctuating weather patterns, and the widespread transmission of viral infections. These elements collectively result in a higher occurrence of cough and cold-related symptoms among populations, consequently driving demand for cough syrups as a reliable treatment option. As more individuals seek relief from these common yet bothersome ailments, the cough syrup market is expected to experience continued growth and expansion.

Restraints in the Global Cough Syrup Market

One of the major constraints facing the global cough syrup market is the stringent regulations aimed at preventing the misuse of these products, especially those that contain codeine or other addictive components. Authorities and governments worldwide are increasingly enforcing strict controls and imposing prescription requirements to combat potential abuse and misuse of cough syrups. These regulations are intended to safeguard public health but can inadvertently restrict access to these medications for legitimate consumers. Consequently, such limitations may hinder the overall growth potential of the cough syrup market, as manufacturers must navigate a complex landscape of compliance and risk management.

Market Trends of the Global Cough Syrup Market

The Global Cough Syrup market is witnessing a significant shift towards natural and plant-based formulations, driven by heightened consumer awareness regarding health and wellness. As more individuals prioritize holistic health solutions, there is a marked increase in demand for cough syrups containing herbal extracts and other natural ingredients, which are perceived as safer alternatives to synthetic products. This trend reflects a growing consumer preference for sustainable and effective healthcare options, with an emphasis on the efficacy of natural remedies in alleviating cough and cold symptoms. Consequently, manufacturers are focusing on developing innovative, eco-friendly cough syrup products to cater to this evolving consumer landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cough Syrup Market Size by Product & CAGR (2025-2032)

• Market Overview
• Expectorants
• Cough Suppressants
• Antihistamines
• Combination Medication

Global Cough Syrup Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Cough Syrup Market Size by Distribution & CAGR (2025-2032)

• Market Overview
• Retail
• Pharmacy
• Hospital
• Others

Global Cough Syrup Market Size & CAGR (2025-2032)

• North America (Product, Age Group, Distribution)
  • US
  • Canada
• Europe (Product, Age Group, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Age Group, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Age Group, Distribution)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Age Group, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dabur India Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himalaya Wellness Company (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals International, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtech Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations